Addex Therapeutics Ltd (SWX:ADXN)
0.0498
-0.0002 (-0.40%)
At close: Jan 30, 2026
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
79.27K CHF
Profits / Employee
-3.05M CHF
Market Cap
5.81M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2 | -21 | -91.30% |
| Dec 31, 2023 | 23 | -1 | -4.17% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | 27 | 8 | 42.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Basilea Pharmaceutica AG | 180 |
| Molecular Partners AG | 153 |
| Santhera Pharmaceuticals Holding AG | 79 |
| BioVersys AG | 29 |
| Newron Pharmaceuticals | 22 |
| Xlife Sciences AG | 17 |
Addex Therapeutics News
- 24 days ago - Addex Therapeutics (ADXN) Advances NTX-253 into Clinical Trials for Schizophrenia - GuruFocus
- 24 days ago - Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia - GlobeNewsWire
- 7 weeks ago - Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co. - GlobeNewsWire
- 2 months ago - Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... - GuruFocus
- 2 months ago - Q3 2025 Addex Therapeutics Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Earnings Scheduled For December 4, 2025 - Benzinga
- 2 months ago - Addex Therapeutics GAAP EPS of -CHF 0.01, income of CHF 0.05M - Seeking Alpha